473567-47-4

Basic information

• Product Name: L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-3,5-difluoro-, methyl ester
• Synonyms: (2S)-2-[(tert-butoxycarbonyl)amino]-3-(3,5-difluorophenyl)propanoic acid methyl ester;(S)-methyl 2-(tert-butoxycarbonylamino)-3-(3,5-difluorophenyl)propanoate;(S)-2-t-butoxycarbonylamino-3-(3,5-difluorophenyl)propionic acid methyl ester;(2S)-2-[(tert-butoxycarbonyl)amino]-3-(3,5-difluorophenyl)propionic acid methyl ester
• CAS NO: 473567-47-4
• Molecular Formula: C15H19F2NO4
• Molecular Weight: 315.317
• Mol File: 473567-47-4.mol
• Article Data: 12

Chemical Properties

• Melting Point: 78 - 80 °C
• Boiling Point: 398.5±42.0 °C(Predicted)
• Density: 1.201±0.06 g/cm3(Predicted)
• CAS DataBase Reference: L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-3,5-difluoro-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-3,5-difluoro-, methyl ester(473567-47-4)
• EPA Substance Registry System: L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-3,5-difluoro-, methyl ester(473567-47-4)

Safety Data

• Hazardous Substances Data: 473567-47-4(Hazardous Substances Data)

Upstream product

• 205445-52-9 (2S)-2-[(tert-butoxycarbonyl)amino]-3-(3,5-difluorophenyl)propanoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 477790-41-3 (Z)-methyl 2-(tert-butoxycarbonyl)amino-3-(3,5-difluorophenyl)acrylate 
• 2265-91-0 1,3-difluoro-5-iodobenzene 
• 93267-04-0 N-(tert-butoxycarbonyl)-L-3-iodoalanine methyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 473567-59-8 methyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 388072-77-3 [(S)-1-(3,5-difluorobenzyl)-3-chloro-2-oxo-propyl]-carbamic acid t-butyl ester 
• 473567-59-8 methyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate 
• 881424-35-7 (1S,2S)-[1-(3,5-difluoro-benzyl)-2-hydroxy-3-iodo-propyl]-carbamic acid tert-butyl ester 
• 845973-58-2 C₃₇H₄₈F₂N₆O₈S 
• 845973-54-8 C₄₀H₅₀F₂N₄O₆ 
• 845973-35-5 C₄₀H₅₀F₂N₄O₆ 
• 845973-56-0 C₃₃H₄₄F₂N₄O₆ 
• 845973-40-2 C₄₂H₄₇F₂N₃O₄ 
• 845973-08-2 C₃₆H₃₉F₂N₃O₃ 
• 845973-72-0 C₃₆H₄₈F₂N₂O₃Si 
• 845973-13-9 C₃₂H₃₁F₂N₃O₂ 
• 845973-62-8 C₃₂H₃₄F₂N₂O₄ 
• 845973-06-0 C₃₅H₃₂F₂N₂O 
• 845973-12-8 C₃₁H₃₂F₂N₂O₃ 

Relevant articles and documents

MaxPHOS ligand: PH/NH tautomerism and rhodium-catalyzed asymmetric hydrogenations

MaxPHOS is an active and robust P-stereogenic ligand for asymmetric catalysis. The presence of an -NH- bridge between the two phosphine moieties allows the NH/PH tautomerism to take place. The neutral ligand, in which the NH form predominates, is an air-sensitive compound. However, protonation of MaxPHOS leads to the stable PH form of the ligand, in which the overall positive charge is distributed on both P centers. This protonation turns the MaxPHOS×HBF4 salt 3 into an air-stable compound both in the solid state and in solution. The salt 3 is also a convenient precursor for the preparation of rhodium(I) complexes by direct ligand exchange with the complex [Rh(acac)(cod)]. Finally, the corresponding rhodium(I)-MaxPHOS complex was tested in the asymmetric hydrogenation of a wide range of substrates. The complex proved to be a highly selective and robust system in these reactions.

BETA-SECRETASE INHIBITING COMPOUNDS HAVING OXO-DIHYDRO-PYRAZOLE MOIETY

Disclosed are compounds represented by Formula (I) as defined in the specification, or pharmaceutically acceptable salts or isomers thereof, and a pharmaceutical composition for inhibiting beta-secretase activity comprising a therapeutically effective amo

Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives

We describe synthesis and evaluation of a series of cyclic urea derivatives with hydroxylethylamine isostere. Modification of P3, P1, and P2′ and combination of SAR display a >100-fold increase in potency with good cellular activity (IC50 = 0.1